IGBA Perspectives on Pandemic Accord (Zero Draft – April 2023)
The criticality of supply chain resilience has become increasingly apparent in recent years, including for essential medicines and health products. The COVID-19 pandemic and geopolitical tensions have highlighted certain vulnerabilities of global supply chains, particularly in the areas of raw materials, manufacturing, transportation, and logistics. Early in COVID 19 pandemic, widespread disruption of global trade created challenges for the uninterrupted supply of essential medicines, underscoring the importance of uniform support for resilient global supply chains.
